ENTO

Entero Therapeutics

17 hedge funds and large institutions have $1.11M invested in Entero Therapeutics in 2020 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 4 closing their positions.

Holders
17
Holders Change
+1
Holders Change %
+6.25%
% of All Funds
0.34%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
5
Increased
4
Reduced
2
Closed
4
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
Vanguard Group
1
Vanguard Group
Pennsylvania
$521K 732,132 +44,968 +7%
Bank of New York Mellon
2
Bank of New York Mellon
New York
$153K 215,313 +215,313 New
PCM
3
Parsons Capital Management
Rhode Island
$127K 178,203
WIA
4
World Investment Advisors
California
$57K 80,000
WPW
5
Waldron Private Wealth
Pennsylvania
$49K 69,835
Wells Fargo
6
Wells Fargo
California
$40K 56,020 +55,893 +44,010%
US Bancorp
7
US Bancorp
Minnesota
$36K 51,020 +51,020 New
Geode Capital Management
8
Geode Capital Management
Massachusetts
$30K 43,085
BPA
9
Beacon Pointe Advisors
California
$28K 39,363 +39,363 New
AAP
10
Ardsley Advisory Partners
Connecticut
$21K 30,000
TCM
11
Traynor Capital Management
Pennsylvania
$20K 24,999 +24,999 New
Northern Trust
12
Northern Trust
Illinois
$14K 19,483 -3,536 -15%
BlackRock
13
BlackRock
New York
$11K 15,338 +6 +0%
PFGIA
14
Patriot Financial Group Insurance Agency
Massachusetts
$4K 6,250 -9,000 -59%
HFM
15
Hartford Financial Management
Connecticut
$1K 1,000
PMFA
16
Plante Moran Financial Advisors
Michigan
$1K 800 +800 New
Renaissance Technologies
17
Renaissance Technologies
New York
-143,500 Closed
TA
18
Tiedemann Advisors
New York
-63,460 Closed
Squarepoint
19
Squarepoint
New York
-39,439 Closed
TRCT
20
Tower Research Capital (TRC)
New York
-15,557 Closed
CFGS
21
Concourse Financial Group Securities
Alabama
Royal Bank of Canada
22
Royal Bank of Canada
Ontario, Canada
$0 476 +194 +69%